Recent improvements in newborn wearable systems, concentrating on skin-interfaced wearables for physiological monitoring across many branches.
New Bispecific Antibody Nabs Conditional FDA Approval for Myeloma
The FDA granted accelerated approval to the bispecific antibody elranatamab (Elrexfio) for relapsed/refractory multiple myeloma treated with at least four prior regimens. A B-cell maturation
August 16, 2023